Document Detail


Angiotensin converting-enzyme inhibitors and candesartan have no effects on atrial fibrillation after cardiac surgery: comment on: Mehmet Ozaydin et al. "Effect of renin-angiotensin aldosterone system blockers on postoperative atrial fibrillation".
MedLine Citation:
PMID:  19101048     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The manuscript is a "Letter to the Editor" concerning the paper: "Ozaydin M, Dede O, Varol E, et al. Effect of renin-angiotensin aldosteron system blockers on postoperative atrial fibrillation. Int J Cardiol 2008; 127: 362-367".
Authors:
Giovanni Mariscalco; Carmelo Dominici; Maciej Banach; Andrea Sala
Related Documents :
11220518 - Maintenance of sinus rhythm as a therapy goal.
16615278 - Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old.
7270438 - Relation between conduction delay and ventricular fibrillation: characteristics of cond...
1874648 - Atrial fibrillation during a subarachnoid block in a patient with undiagnosed mitral va...
12598068 - Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular rem...
1372968 - Is the morphology of ventricular premature beats a marker for left ventricular dysfunct...
Publication Detail:
Type:  Comment; Letter     Date:  2008-12-19
Journal Detail:
Title:  International journal of cardiology     Volume:  142     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-14     Completed Date:  2011-02-22     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  209-10     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angiotensin II Type 1 Receptor Blockers / administration & dosage
Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
Atrial Fibrillation / drug therapy*,  etiology,  metabolism
Benzimidazoles / administration & dosage*
Cardiac Surgical Procedures / adverse effects*
Humans
Mineralocorticoid Receptor Antagonists / administration & dosage
Postoperative Complications / drug therapy*,  etiology,  metabolism
Prospective Studies
Renin-Angiotensin System / drug effects*,  physiology
Tetrazoles / administration & dosage*
Chemical
Reg. No./Substance:
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Benzimidazoles; 0/Mineralocorticoid Receptor Antagonists; 0/Tetrazoles; S8Q36MD2XX/candesartan
Comments/Corrections
Comment On:
Int J Cardiol. 2008 Jul 21;127(3):362-7   [PMID:  17692951 ]
Comment In:
Int J Cardiol. 2010 Oct 8;144(2):273-4   [PMID:  19232756 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Adverse local reactions to the use of hydrophilic sheaths for radial artery canulation.
Next Document:  Pulmonary hypertension in systemic sclerosis determines cardiac autonomic dysfunction assessed by he...